JAK2 and neoplasm: In addition, we found that the interaction network involving JHDM1D/KDM7A was associated with RAF1, ARAF, JAK2, and CAMK2 activation, reinforcing the involvement of JHDM1D/KDM7A in tumor aggressiveness and progression.